Order Article Reprints

Carcione D, Brigante G, Carducci A, Intra J, Ambretti S, Campanile F, Arcari G, Mancini N, Cattaneo D, Gona F, et al. Cefepime and New Cefepime/Beta-Lactamase Inhibitor Combination for the Treatment of Gram-Negative Bacteria: Chemical Structure and Mechanism of Action, Microbiological Target, Clinical Use and PK/PD Characteristics. Pharmaceuticals. 2026; 19(2):283. https://doi.org/10.3390/ph19020283

Carcione, Davide, Gioconda Brigante, Antonella Carducci, Jari Intra, Simone Ambretti, Floriana Campanile, Gabriele Arcari, Nicasio Mancini, Dario Cattaneo, Floriana Gona, and et al. 2026. "Cefepime and New Cefepime/Beta-Lactamase Inhibitor Combination for the Treatment of Gram-Negative Bacteria: Chemical Structure and Mechanism of Action, Microbiological Target, Clinical Use and PK/PD Characteristics" Pharmaceuticals 19, no. 2: 283. https://doi.org/10.3390/ph19020283

Carcione, D., Brigante, G., Carducci, A., Intra, J., Ambretti, S., Campanile, F., Arcari, G., Mancini, N., Cattaneo, D., Gona, F., Perilli, M., Piccirilli, A., Geremia, N., Zerbato, V., Di Bella, S., Nicolò, G. M., & Principe, L. (2026). Cefepime and New Cefepime/Beta-Lactamase Inhibitor Combination for the Treatment of Gram-Negative Bacteria: Chemical Structure and Mechanism of Action, Microbiological Target, Clinical Use and PK/PD Characteristics. Pharmaceuticals, 19(2), 283. https://doi.org/10.3390/ph19020283